论文部分内容阅读
Objective To investigate effect of intravenou s infusion Mailuoning for hypertensive cerebral hemorrhage on the drape in stable phase.Methods412subjects with hypertensive cere bral hemorrhage on the drape in stable phase were divided into two groups:Mailuoning group(n =208),and control group(n =204).In control group,the routine thera py method was administered.In Mailu oning group,besides routine therapy program,20ml Mailuoning pa renteral solution was injected i.v o nce a day.Therapy period is 21days.A ccording to European Strokes Scale,the clinical neurologic impa irment score and average value were e valuated when the put in hospital and after the course 4weeks were evaluated between Mailuoning group and control group.At the same time,d eath rate was compared.Result When the observation is end,the both average value of the clinical neurologic impairment score(14.2±4.8)and amount of hematom(9.4±3.7)ml of the Mailuoning group infra the control group(15.6±4.6,10.8±3.9)ml,U >2.56.Mailuoning group death r ate infra control group(6.37%),P <0.05.Conclusion Mailuoning parenteral solution can facilitate hemorrhage acceleratio n and descent of the clinical neurolo gic impairment score and death rate of the patients with hypertensive cerebral hemorrhage in s table phase.It is reliable that Mail uoning parenteral solution treats t he patients with hypertensive cerebra l hemorrhage in stable phase.
Objective To investigate the effect of intravenou s infusion Mailuoning for hypertensive cerebral hemorrhage on the drape in stable phase. Methods 412 syubjects with hypertensive cere bral hemorrhage on the drape in stable phase were divided into two groups: Mailuoning group (n = 208), and control group ( n = 204) .In control group, the routine thera py method was administered.In Mailu oning group, besides routine therapy program, 20ml Mailuoning pa renteral solution was injected iv o nce a day .rapy period is 21days. A ccording to European Strokes Scale, the clinical neurologic impa irment score and average value were e valuated when the put in hospital and after the course 4 weeks were evaluated between Mailuoning group and control group. At the same time, d eath rate was compared. Result When the observation is end , the both average value of the clinical neurologic impairment score (14.2 ± 4.8) and the amount of hematom (9.4 ± 3.7) ml of the Mailuoning group infra the control group (15.6 ± 4.6,10.8 ± 3.9) ml, U> 2.56.Ma iluoning group death r ate infra control group (6.37%), P <0.05.Conclusion Mailuoning parenteral solution could facilitate hemorrhage acceleratio n and descent of the clinical neurolo gic impairment score and death rate of the patients with hypertensive cerebral hemorrhage in s table phase. It is reliable that Mail uoning parenteral solution treats t he patients with hypertensive cerebra hemorrhage in stable phase.